SpongouridineCAS# 3083-77-0 |
2D Structure
- Uridine
Catalog No.:BCN4090
CAS No.:58-96-8
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 3083-77-0 | SDF | Download SDF |
PubChem ID | 18323 | Appearance | Powder |
Formula | C9H12N2O6 | M.Wt | 244 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Synonyms | Arauridine | ||
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione | ||
SMILES | C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)O | ||
Standard InChIKey | DRTQHJPVMGBUCF-CCXZUQQUSA-N | ||
Standard InChI | InChI=1S/C9H12N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,16)/t4-,6-,7+,8-/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Spongouridine Dilution Calculator
Spongouridine Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.0984 mL | 20.4918 mL | 40.9836 mL | 81.9672 mL | 102.459 mL |
5 mM | 0.8197 mL | 4.0984 mL | 8.1967 mL | 16.3934 mL | 20.4918 mL |
10 mM | 0.4098 mL | 2.0492 mL | 4.0984 mL | 8.1967 mL | 10.2459 mL |
50 mM | 0.082 mL | 0.4098 mL | 0.8197 mL | 1.6393 mL | 2.0492 mL |
100 mM | 0.041 mL | 0.2049 mL | 0.4098 mL | 0.8197 mL | 1.0246 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 4-Oxododecanedioic acid
Catalog No.:BCN5223
CAS No.:30828-09-2
- AEBSF.HCl
Catalog No.:BCC1219
CAS No.:30827-99-7
- L-Theanine
Catalog No.:BCN2571
CAS No.:3081-61-6
- beta-Anhydrouzarigenin
Catalog No.:BCN5222
CAS No.:3080-20-4
- [Des-octanoyl]-Ghrelin (rat)
Catalog No.:BCC5953
CAS No.:307950-60-3
- Crosemperine
Catalog No.:BCN2074
CAS No.:30785-56-9
- STF 083010
Catalog No.:BCC6209
CAS No.:307543-71-1
- SMER 28
Catalog No.:BCC7908
CAS No.:307538-42-7
- CFTRinh-172
Catalog No.:BCC4419
CAS No.:307510-92-5
- Troxipide
Catalog No.:BCC4744
CAS No.:30751-05-4
- 1,4-Bis[2-(4-methyl-5-phenyloxazolyl)]benzene
Catalog No.:BCC8425
CAS No.:3073-87-8
- WAY 170523
Catalog No.:BCC2380
CAS No.:307002-73-9
- PM00104
Catalog No.:BCC4237
CAS No.:308359-57-1
- Aloesin
Catalog No.:BCN8437
CAS No.:30861-27-9
- Kauran-18-Olc Acid,16,1719-Tnhydroxy-,(4A)
Catalog No.:BCC9235
CAS No.:308821-59-2
- 8-Epixanthatin
Catalog No.:BCN7782
CAS No.:30890-35-8
- 3β-Acetoxy-5α-androstan-17β-ol
Catalog No.:BCC8644
CAS No.:3090-70-8
- Boc-N-Me-Phg-OH
Catalog No.:BCC3350
CAS No.:30925-11-2
- Boc-Asp-OBzl
Catalog No.:BCC3363
CAS No.:30925-18-9
- Inauhzin
Catalog No.:BCC5146
CAS No.:309271-94-1
- Doxifluridine
Catalog No.:BCC4903
CAS No.:3094-09-5
- Perillartine
Catalog No.:BCN8305
CAS No.:30950-27-7
- 2-Amino-9H-fluoren-9-one
Catalog No.:BCC8545
CAS No.:3096-57-9
- 1,5-Dicaffeoylquinic acid
Catalog No.:BCN5913
CAS No.:30964-13-7
Chemistry and Biological Activities of the Marine Sponges of the Genera Mycale (Arenochalina), Biemna and Clathria.[Pubmed:29912171]
Mar Drugs. 2018 Jun 18;16(6). pii: md16060214.
Over the past seven decades, particularly since the discovery of the first marine-derived nucleosides, spongothymidine and Spongouridine, from the Caribbean sponge Cryptotethya crypta in the early 1950s, marine natural products have emerged as unique, renewable and yet under-investigated pools for discovery of new drug leads with distinct structural features, and myriad interesting biological activities. Marine sponges are the most primitive and simplest multicellular animals, with approximately 8900 known described species, although more than 15,000 species are thought to exist worldwide today. These marine organisms potentially represent the richest pipeline for novel drug leads. Mycale (Arenochalina) and Clathria are recognized marine sponge genera belonging to the order Poecilosclerida, whereas Biemna was more recently reclassified, based on molecular genetics, as a new order Biemnida. Together, these sponge genera contribute to the production of physiologically active molecular entities with diverse structural features and a wide range of medicinal and therapeutic potentialities. In this review, we provide a comprehensive insight and up-to-date literature survey over the period of 1976(-)2018, focusing on the chemistry of the isolated compounds from members of these three genera, as well as their biological and pharmacological activities, whenever available.
Spongosine production by a Vibrio harveyi strain associated with the sponge Tectitethya crypta.[Pubmed:25668560]
J Nat Prod. 2015 Mar 27;78(3):493-9.
Spongosine (1), deoxyspongosine (2), spongothymidine (Ara T) (3), and Spongouridine (Ara U) were isolated from the Caribbean sponge Tectitethya crypta and given the general name "spongonucleosides". Spongosine, a methoxyadenosine derivative, has demonstrated a diverse bioactivity profile including anti-inflammatory activity and analgesic and vasodilation properties. Investigations into unusual nucleoside production by T. crypta-associated microorganisms using mass spectrometric techniques have identified a spongosine-producing strain of Vibrio harveyi and several structurally related compounds from multiple strains.
Pseudouridine, an antimutagenic substance in beer towards N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).[Pubmed:12067579]
Food Chem Toxicol. 2002 Aug;40(8):1165-70.
Previously we reported that beer is antimutagenic against several food-derived mutagens including heterocyclic amines. We describe here the isolation and identification of pseudouridine from beer as an antimutagenic substance against N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). All of the 17 samples of beer tested showed inhibition of the MNNG mutagenicity in Salmonella. Extensive fractionation through chromatography of the active components from a freeze-dried beer sample gave six antimutagenic fractions. One contained pseudouridine, as characterized by the UV spectra, nuclear magnetic resonance, and co-chromatography in HPLC. Pure pseudouridine inhibited the mutagenicity of MNNG in a dose-dependent manner. The amount of pseudouridine in the beer sample, estimated at about 0.4 mg/100 ml beer, can account for 3% of the total antimutagenicity of beer. Thus, the major active components in beer remain to be identified. The role of pseudouridine in inhibiting the mutagenicity of MNNG is to be studied further. Among analogs of pseudouridine, Spongouridine, but not uridine, was antimutagenic against MNNG. The bacterial mutagenicity of another methylating agent N-methyl-N-nitrosourea was also inhibited by pseudouridine. Pseudouridine is the first example among nucleosides to be shown to possess an antimutagenic property.